In consistent with these studies, our data demonstrated that TGF-β1 released from CCA cells activated CAFs and enhanced their abilities of proliferation, migration, and invasion through Smad2/3 pathway activation. The gene discussed is SMAD2; the disease is cholangiocarcinoma.